SCHEMBL20439189

SCHEMBL20439189

CN1CCC2(CC1)CCN(C(=O)N1CCn3cc(C4=C(c5cnc6ccccn56)CNC4=O)c4cc(C#N)cc(c43)C1)C2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 20/20 0.55
PRKCB P05771 6/20 0.55
CDK4 P11802 6/20 0.55
TGFBR2 P37173 3/20 0.55
GSK3A P49840 16/20 0.53
CDK2 P24941 5/20 0.53
CAMK2G Q13555 3/20 0.53
CAMK2D Q13557 3/20 0.53
PDK1 Q15118 3/20 0.53
CDK5 Q00535 3/20 0.53
PRKCG P05129 2/20 0.53
LCK P06239 2/20 0.53
CDK1 P06493 2/20 0.53
PIM1 P11309 2/20 0.53
CLK2 P49760 2/20 0.53
RPS6KA3 P51812 2/20 0.53
PRKCD Q05655 2/20 0.53
DYRK1A Q13627 2/20 0.53
PKN2 Q16513 2/20 0.53
SLK Q9H2G2 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20439107 0.96 GSK3B (0.56) GSK3BPRKCBCDK4TGFBR2GSK3A
SCHEMBL21577692 0.91 GSK3B (0.66) GSK3BPRKCBCDK4TGFBR2GSK3A
SCHEMBL29534131 0.91 GSK3B (0.66) GSK3BPRKCBCDK4TGFBR2GSK3A
SCHEMBL20439085 0.91 GSK3B (0.58) GSK3BPRKCBCDK4TGFBR2GSK3A
SCHEMBL20439153 0.91 GSK3B (0.66) GSK3BPRKCBCDK4TGFBR2GSK3A
SCHEMBL20439082 0.89 GSK3B (0.57) GSK3BPRKCBCDK4TGFBR2GSK3A
SCHEMBL20439227 0.89 GSK3B (0.65) GSK3BPRKCBCDK4TGFBR2GSK3A
SCHEMBL20439152 0.87 GSK3B (0.67) GSK3BPRKCBCDK4TGFBR2GSK3A
SCHEMBL20439084 0.87 GSK3B (0.56) GSK3BPRKCBCDK4TGFBR2GSK3A
SCHEMBL22510842 0.86 GSK3B (0.52) GSK3BPRKCBCDK4TGFBR2GSK3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10383881-B2 1,5-dihydro-2H-pyrrol-2-one compounds and methods of using same Frequency Therapeutics, Inc. (US) 2019-08-20 US disclosed
US-20180214458-A1 1,5-DIHYDRO-2H-PYRROL-2-ONE COMPOUNDS AND METHODS OF USING SAME Frequency Therapeutics, Inc. 2018-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180214458-A1 1,5-DIHYDRO-2H-PYRROL-2-ONE COMPOUNDS AND METHODS OF USING SAME DCX, MKI67, MCL1 GSK3B 3480/4885PRKCB 2056/4885CDK4 79/4885
US-10383881-B2 1,5-dihydro-2H-pyrrol-2-one compounds and methods of using same DCX, MKI67, MCL1 GSK3B 3480/4885PRKCB 2056/4885CDK4 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.